RESEARCH GROUPS

Projects

• Efectividad de la intervención MultiPAP Plus en ancianos jóvenes con multimorbilidad y polimedicación para mejorar la prescripción en atención primaria: ECA por conglomerados

  Principal Investigator: Prados Torres, Juan Daniel

  Funding entity: (2018 - 2023)

• Efectividad de la intervencion MultiPAP Plus en ancianos jovenes con multimorbilidad y polimedicacion para mejorar la prescripcion en atencion primaria: ECA por conglomerados

  Principal Investigator: Del Cura González, Isabel

  Funding entity: (2022)

Recent publications

• Corominas J, Garriga C, Prenafeta A, Moros A, Cañete M, Barreiro A, González-González L, Madrenas L, Güell I, Clotet B, Izquierdo-Useros N, Raïch-Regué D, Gallemí M, Blanco J, Pradenas E, Trinité B, Prado JG, Blanch-Lombarte O, Pérez-Caballero R, Plana M, Esteban I, Pastor-Quiñones C, Núñez-Costa X, Taleb RA, McSkimming P, Soriano A, Nava J, Anagua JO, Ramos R, Lluch RM, Comes AC, Romero SO, Gomez XM, Sans-Pola C, Moltó J, Benet S, Bailón L, Arribas JR, Borobia AM, Parada JQ, Navarro-Pérez J, Forner Giner MJ, Lucas RO, Jiménez MDMV, Compán SO, Alvarez-Mon M, Troncoso D, Arana-Arri E, Meijide S, Imaz-Ayo N, García PM, de la Villa Martínez S, Fernández SR, Prat T, Torroella È, Ferrer L. Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial. Lancet Reg Health Eur. 2023 May; 28:100613. doi:10.1016/j.lanepe.2023.100613. Epub 2023 Apr 14. pmc:PMC10102678. PMID:37131861.

• Leiva-Fernández F, Prados-Torres JD, Prados-Torres A, Del-Cura-González I, Castillo-Jimena M, López-Rodríguez JA, Rogero-Blanco ME, Lozano-Hernández CM, López-Verde F, Bujalance-Zafra MJ, Pico-Soler MV, Gimeno-Feliu LA, Poblador-Plou B, Martinez-Cañavate MT, Muth C; MULTIPAP Group. Training primary care professionals in multimorbidity management: Educational assessment of the eMULTIPAP course. Mech Ageing Dev. 2020 Dec; 192:111354. doi:10.1016/j.mad.2020.111354. Epub 2020 Sep 15. PMID:32946885.

• Lopez-Rodriguez JA, Rogero-Blanco E, Aza-Pascual-Salcedo M, Lopez-Verde F, Pico-Soler V, Leiva-Fernandez F, Prados-Torres JD, Prados-Torres A, Cura-González I; MULTIPAP group. Potentially inappropriate prescriptions according to explicit and implicit criteria in patients with multimorbidity and polypharmacy. MULTIPAP: A cross-sectional study. PLoS One. 2020 ; 15(8):e0237186. doi:10.1371/journal.pone.0237186. Epub 2020 Aug 12. pmc:PMC7423095. PMID:32785232.

• Prados-Torres A, Cura-González ID, Prados-Torres JD, Muth C, Leiva-Fernández F, Lopez-Rodriguez JA, González-Rubio F. MULTIPAP Study: Improving healthcare for patients with multimorbidity. Br J Gen Pract. 2020 Jun; 70(suppl 1). doi:10.3399/bjgp20X711257. PMID:32554653.

• Prados-Torres A, Del Cura-González I, Prados-Torres D, López-Rodríguez JA, Leiva-Fernández F, Calderón-Larrañaga A, López-Verde F, Gimeno-Feliu LA, Escortell-Mayor E, Pico-Soler V, Sanz-Cuesta T, Bujalance-Zafra MJ, Morey-Montalvo M, Boxó-Cifuentes JR, Poblador-Plou B, Fernández-Arquero JM, González-Rubio F, Ramiro-González MD, Coscollar-Santaliestra C, Martín-Fernández J, Barnestein-Fonseca MP, Valderas-Martínez JM, Marengoni A, Muth C; Multi-PAP Group. Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: study protocol of a cluster randomized clinical trial (Multi-PAP project). Implement Sci. 2017 Apr; 12(1):54. doi:10.1186/s13012-017-0584-x. Epub 2017 Apr 27. pmc:PMC5406997. PMID:28449721.

• Prados-Torres A, Del Cura-González I, Prados-Torres JD, Leiva-Fernández F, López-Rodríguez JA, Calderón-Larrañaga A, Muth C. [Multimorbidity in general practice and the Ariadne principles. A person-centred approach]. Aten Primaria. 2017 May; 49(5):300-307. doi:10.1016/j.aprim.2016.11.013. Epub 2017 Apr 17. Spanish. pmc:PMC6875989. PMID:28427915.